Transfusion reaction: Difference between revisions

Jump to navigation Jump to search
 
(28 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{SI}}
{{SI}}
{{CMG}}
{{CMG}} {{shyam}}; {{AE}} [https://www.wikidoc.org/index.php/User:K.Nouman <nowiki>Khuram Nouman, M.D. [2]</nowiki>]  {{ADS}}


==Overview==
==Overview==
In [[medicine]], a '''transfusion reaction''' is any [[adverse event]] which occurs because of a [[blood transfusion]]. These events can take the form of an [[allergic reaction]], a transfusion-related [[infection]], [[hemolysis]] related to an [[cross-matching|incompatible]] [[blood type]], or an alteration of the [[immune system]] related to the transfusion. The risk of a transfusion reaction must always be balanced against the anticipated benefit of a blood transfusion.
Blood products, when transfused even after cross matching, elicit some reactions. The transfusion reactions are classified into [[anaphylactic]] reaction, bacterial infection, acute hemolytic reaction, febrile non-hemolytic reaction, [[transfusion related acute lung injury|transfusion-related acute lung injury]][[TRALI]], [[transfusion-associated circulatory overload]], transfusion-associated microchimerism (TA-MC), iron overload, and transfusion-associated [[Graft-versus-host disease|Graft-versus-Host Disease]] (GvHD). The symptoms may range from fever to life threatening [[anaphylaxis]]. The treatment of each different type of transfusion reaction is different.


==Types of Transfusion Reactions==
==Types of Transfusion Reactions==


===Febrile Non-hemolytic Transfusion Reaction===
===Anaphylactic Reaction===
This is the most common adverse reaction to a blood transfusion. Symptoms include [[fever]] and [[dyspnea]] 1 to 6 hours after receiving the transfusion. Such reactions are clinically benign, causing no lasting side effects or problems, but are unpleasant via a blood transfusion is estimated, as of 2006, at 1 per 2 million units transfused. [[Bacteria]]l infection is a much more common problem (see below).
*An [[anaphylaxis|anaphylactic]] (or severe [[Allergy|allergic]]) reaction can occur at a rate of 1 per 30,000-50,000 [[Blood transfusion|transfusions]].  
*These reactions are most common in people with [[selective IgA deficiency]] (although IgA deficiency is often [[asymptomatic]], and people may not know they have it until an anaphylactic reaction occurs).  
===Bacterial Infection===
===Bacterial Infection===
Blood products can provide an excellent medium for [[bacteria]]l growth, and can become contaminated after collection while they are being stored. The risk is highest with [[platelet]] transfusion, since platelets must be stored near room temperature and cannot be refrigerated. The risk of severe bacterial infection and [[sepsis]] is estimated (as of 2001) at about 1 in 50,000 platelet transfusions, and 1 in 500,000 red blood cell transfusions.<ref>Bacterial contamination of platelet concentrates: incidence, significance, and prevention. Blajchman MA; Goldman M. Semin Hematol 2001 Oct;38(4 Suppl 11):20-6.</ref>
*Blood products can provide an excellent medium for [[bacteria]]l growth, and can become contaminated after collection while they are being stored.  
*The risk is highest with [[platelet]] transfusion, since platelets must be stored near room temperature and cannot be refrigerated.  
*The risk of severe bacterial infection and [[sepsis]] is estimated (as of 2001) at about 1 in 50,000 platelet transfusions, and 1 in 500,000 red blood cell transfusions.
===Acute Hemolytic Reaction===
===Acute Hemolytic Reaction===
This is a [[medical emergency]] resulting from rapid destruction ([[hemolysis]]) of the donor red blood cells by host [[antibody|antibodies]]. The most common cause is [[clerical error]] (i.e. the wrong unit of blood being given to the wrong patient). The symptoms are [[fever]] and chills, sometimes with [[back pain]] and pink or red urine ([[hemoglobinuria]]). The major complication is that [[hemoglobin]] released by the destruction of red blood cells can cause [[acute renal failure]].
*This is a [[medical emergency]] resulting from rapid destruction ([[hemolysis]]) of the donor red blood cells by host [[antibody|antibodies]].  
===Anaphylactic Reaction===
*The most common cause is [[clerical error]] (i.e. the wrong unit of blood being given to the wrong patient).  
An [[anaphylaxis|anaphylactic]] (or severe allergic) reaction can occur at a rate of 1 per 30,000-50,000 transfusions. These reactions are most common in people with [[selective IgA deficiency]] (although IgA deficiency is often [[asymptomatic]], and people may not know they have it until an anaphylactic reaction occurs). An anaphylactic reaction is a [[medical emergency]], requiring prompt treatment, and may be life-threatening.
*The symptoms are [[fever]] and chills, sometimes with [[back pain]] and pink or red urine ([[hemoglobinuria]]).  
===Transfusion-associated Acute Lung Injury (TRALI)
*The major complication is that [[hemoglobin]] released by the destruction of red blood cells can cause [[acute renal failure]].
[[TRALI]] is a syndrome of acute [[respiratory distress]], often associated with [[fever]], non-cardiogenic [[pulmonary edema]], and [[hypotension]]. It may occur as often as 1 in 2000 transfusions.<ref>The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Silliman CC; Paterson AJ; Dickey WO; Stroneck DF; Popovsky MA; Caldwell SA; Ambruso DR. Transfusion 1997 Jul;37(7):719-26.</ref> Symptoms can range from mild to life-threatening, but most patients recover fully within 96 hours, and the mortality rate from this condition is less than 10%.<ref>Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Popovsky MA; Chaplin HC Jr; Moore SB. Transfusion 1992 Jul-Aug;32(6):589-92.</ref>
===Febrile Non-hemolytic Transfusion Reaction===
*This is the most common adverse reaction to a blood transfusion.  
*Symptoms include [[fever]] and [[dyspnea]] 1 to 6 hours after receiving the transfusion.
*Such reactions are clinically benign, causing no lasting side effects or problems, but are unpleasant via a blood transfusion is estimated, as of 2006, at 1 per 2 million units transfused. [[Bacteria]]l infection is a much more common problem.
===Transfusion-Related Acute Lung Injury (TRALI)===
*[[TRALI]] is a syndrome of acute [[respiratory distress]], often associated with [[fever]], non-cardiogenic [[pulmonary edema]], and [[hypotension]].  
*It may occur as often as 1 in 2000 transfusions.  
*Symptoms can range from mild to life-threatening, but most patients recover fully within 96 hours, and the mortality rate from this condition is less than 10%.
===Transfusion-associated Microchimerism (TA-MC)===
*Transfusion-associated [[Chimera (genetics)#Microchimerism|microchimerism]] is the stable persistence of donor's genetically distinct cells (usually <5%) in a recipient's circulation following fresh [[blood transfusion]], especially in the setting of [[Physical trauma|trauma]].
*As a result of the current advancement in [[polymerase chain reaction]] techniques, TA-MC has been demonstrated among patients with [[Physical trauma|trauma]] following [[blood transfusion]], [[pregnancy]] and [[transplant|organ or stem cell transplantation]].  Several studies have implicated other forms of [[Chimera (genetics)#Microchimerism|microchimerism]], including [[Chimera (genetics)|fetomaternal microchimerism]], with acute and chronic illnesses such as [[congenital heart block]] in a patient with [[neonatal lupus erythematosus]] and [[systemic sclerosis]].
*Genetic factors such as the [[Tumor necrosis factors|TNF]] (-308A) [[single nucleotide polymorphism]]s (SNP) have been implicated in the development of TA-MC.  The risk of developing TA-MC is largely dependent on the clinical setting, i.e., it is rare in situations which do not involve massive trauma.  Although [[leukoreduction]] removes > 99.9% of donor's [[white blood cell]]s, it has not been proven to prevent the development of TA-MC.
===Transfusion-associated Graft-vs-Host Disease (GvHD)===
*[[graft-versus-host disease|GVHD]] refers to an immune attack by transfused cells against the recipient. This is a common complication of [[stem cell transplant]]ation, but an exceedingly rare complication of blood transfusion.
*It occurs only in severely immunosuppressed patients, primarily those with [[congenital]] immune deficiencies or [[hematological malignancy|hematologic malignancies]] who are receiving intensive [[chemotherapy]].
*When GVHD occurs in association with blood transfusion, it is almost uniformly fatal. Transfusion-associated GVHD can be prevented by [[irradiation|irradiating]] the blood products prior to transfusion.
===Volume Overload===
===Volume Overload===
Patients with impaired cardiac function (eg [[congestive heart failure]]) can become volume-overloaded as a result of blood transfusion, leading to [[edema]], [[dyspnea]] (shortness of breath), and [[orthopnea]] (shortness of breath while lying flat). This is sometimes called TACO, or Transfusion Associated Circulatory Overload.
*Patients with impaired cardiac function (e.g. [[congestive heart failure]]) can become volume-overloaded as a result of blood transfusion, leading to [[edema]], [[dyspnea]] (shortness of breath), and [[orthopnea]] (shortness of breath while lying flat).  
===Iron overload===
*This is sometimes called TACO, or Transfusion Associated Circulatory Overload.<ref>Suddock JT, Crookston KP. Transfusion Reactions. [Updated 2018 Sep 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482202/</ref>
Each transfused unit of [[red blood cell]]s contains approximately 250 mg of elemental [[iron]]. Since elimination pathways for iron are limited, a person receiving numerous red blood cell transfusions can develop [[iron overload]], which can in turn damage the [[liver]], [[heart]], [[kidney]]s, and [[pancreas]]. The threshold at which iron overload becomes significant is somewhat unclear, but is likely around 12-20 units of red blood cells transfused.  
 
===Transfusion-associated Graft-vs-Host Disease (GvHD)===
===Iron Overload===
[[graft-versus-host disease|GVHD]] refers to an immune attack by transfused cells against the recipient. This is a common complication of [[stem cell transplant]]ation, but an exceedingly rare complication of blood transfusion. It occurs only in severely immunosuppressed patients, primarily those with [[congenital]] immune deficiencies or [[hematological malignancy|hematologic malignancies]] who are receiving intensive [[chemotherapy]]. When GVHD occurs in association with blood transfusion, it is almost uniformly fatal.<ref>Transfusion-associated graft-versus-host disease and blood irradiation. Linden JV; Pisciotto PT. Transfus Med Rev 1992 Apr;6(2):116-23.</ref> Transfusion-associated GVHD can be prevented by [[irradiation|irradiating]] the blood products prior to transfusion.
*Each transfused unit of [[red blood cell]]s contains approximately 250 mg of elemental [[iron]].  
===Transfusion-associated Microchimerism (TA-MC)===
*Since elimination pathways for iron are limited, a person receiving numerous red blood cell transfusions can develop [[iron overload]], which can in turn damage the [[liver]], [[heart]], [[kidney]]s, and [[pancreas]]. The threshold at which iron overload becomes significant is somewhat unclear, but is likely around 12-20 units of red blood cells transfused.
Transfusion-associated [[Chimera (genetics)#Microchimerism|microchimerism]] is the stable persistence of donor's genetically distinct cells (usually <5%) in a recipient's circulation following fresh [[blood transfusion]], especially in the setting of [[Physical trauma|trauma]].<ref name="pmid18766299">{{cite journal| author=Kunadian V, Zorkun C, Gibson WJ, Nethala N, Harrigan C, Palmer AM et al.| title=Transfusion associated microchimerism: a heretofore little-recognized complication following transfusion. | journal=J Thromb Thrombolysis | year= 2009 | volume= 27 | issue= 1 | pages= 57-67 | pmid=18766299 | doi=10.1007/s11239-008-0268-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18766299  }} </ref> As a result of the current advancement in [[polymerase chain reaction]] techniques, TA-MC has been demonstrated among patients with [[Physical trauma|trauma]] following [[blood transfusion]], [[pregnancy]] and [[transplant|organ or stem cell transplantation]].  Several studies have implicated other forms of [[Chimera (genetics)#Microchimerism|microchimerism]], including [[Chimera (genetics)|fetomaternal microchimerism]], with acute and chronic illnesses such as [[congenital heart block]] in a patient with [[neonatal lupus erythematosus]]<ref name="pmid14996783">{{cite journal| author=Adams KM, Nelson JL| title=Microchimerism: an investigative frontier in autoimmunity and transplantation. | journal=JAMA | year= 2004 | volume= 291 | issue= 9 | pages= 1127-31 | pmid=14996783 | doi=10.1001/jama.291.9.1127 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14996783  }} </ref> and [[systemic sclerosis]].<ref name="pmid9492775">{{cite journal| author=Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A et al.| title=Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. | journal=Lancet | year= 1998 | volume= 351 | issue= 9102 | pages= 559-62 | pmid=9492775 | doi=10.1016/S0140-6736(97)08357-8 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9492775}} </ref>
Following table summarizes the difference between transfusion-related acute lung injury (TRALI) and transfusion associated circulatory overload (TACO):
Genetic factors such as the [[Tumor necrosis factors|TNF]] (-308A) [[single nucleotide polymorphism]]s (SNP) have been implicated in the development of TA-MC such as the  The risk of developing TA-MC is largely dependent on the clinical setting, i.e., it is rare in situations which do not involve massive trauma.<ref name="pmid21981710">{{cite journal| author=Sanchez R, Lee TH, Wen L, Montalvo L, Schechterly C, Colvin C et al.| title=Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components. | journal=Transfusion | year= 2012 | volume= 52 | issue= 5 | pages= 936-45 | pmid=21981710 | doi=10.1111/j.1537-2995.2011.03366.x | pmc=PMC3257351 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21981710  }} </ref>  Although leukoreduction removes > 99.9% of donor's [[white blood cell]]s, it has not been proven to prevent the development of TA-MC.<ref name="pmid17076839">{{cite journal| author=Utter GH, Nathens AB, Lee TH, Reed WF, Owings JT, Nester TA et al.| title=Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients. | journal=Transfusion | year= 2006 | volume= 46 | issue= 11 | pages= 1863-9 | pmid=17076839 | doi=10.1111/j.1537-2995.2006.00991.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17076839  }} </ref><ref name="pmid16078913">{{cite journal| author=Lee TH, Paglieroni T, Utter GH, Chafets D, Gosselin RC, Reed W et al.| title=High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. | journal=Transfusion | year= 2005 | volume= 45 | issue= 8 | pages= 1280-90 | pmid=16078913 | doi=10.1111/j.1537-2995.2005.00201.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16078913  }} </ref>
{|
! style="background:#4479BA; color: #FFFFFF;" align="center" |Parameters
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion-related acute lung injury (TRALI)
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion-associated circulatory overload (TACO)
|-
! align="center" style="background:#DCDCDC;" |[[Fever]]
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |−
|-
! align="center" style="background:#DCDCDC;" |[[Blood pressure]]
| align="center" style="background:#F5F5F5;" | [[Hypotension]]
| align="center" style="background:#F5F5F5;" | [[Hypertension]]
|-
! align="center" style="background:#DCDCDC;" |[[Respiratory failure|Respiratory distress]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
|-
! align="center" style="background:#DCDCDC;" |[[Jugular venous pressure|JVP]]
| align="center" style="background:#F5F5F5;" | Non-distended
| align="center" style="background:#F5F5F5;" | Distended
|-
! align="center" style="background:#DCDCDC;" |[[Auscultation|Respiratory auscultation]]
| align="center" style="background:#F5F5F5;" | [[Rales]]
| align="center" style="background:#F5F5F5;" | [[Rales]] + [[Heart sounds|S3]] heart sounds may be present
|-
! align="center" style="background:#DCDCDC;" |[[Chest X-ray|CXR]]
| align="center" style="background:#F5F5F5;" | Bilateral [[Lung|pulmonary]] infiltrates
| align="center" style="background:#F5F5F5;" | Bilateral [[Lung|pulmonary]] infiltrates
|-
! align="center" style="background:#DCDCDC;" |[[Fluid balance]]
| align="center" style="background:#F5F5F5;" | Neutral
| align="center" style="background:#F5F5F5;" | Positive
|-
! align="center" style="background:#DCDCDC;" |[[Diuretic|Diuretics]]
| align="center" style="background:#F5F5F5;" | Responsive only when there is fluid overload
| align="center" style="background:#F5F5F5;" | Improvement with [[Diuretic|diuretics]]
|-
! align="center" style="background:#DCDCDC;" |[[Ejection fraction]]
| align="center" style="background:#F5F5F5;" | Normal
| align="center" style="background:#F5F5F5;" | Decreased
|-
! align="center" style="background:#DCDCDC;" |[[Brain natriuretic peptide|BNP]]
| align="center" style="background:#F5F5F5;" | <250 pg/mL
| align="center" style="background:#F5F5F5;" | >1200 pg/mL
|-
! align="center" style="background:#DCDCDC;" |[[Pulmonary capillary wedge pressure|PCWP]]
| align="center" style="background:#F5F5F5;" | <18 mm Hg
| align="center" style="background:#F5F5F5;" | >18 mm Hg
|-
! align="center" style="background:#DCDCDC;" |[[White blood cells|WBC]]
| align="center" style="background:#F5F5F5;" | Unchanged
| align="center" style="background:#F5F5F5;" | Transient decreased
|}


==Treatment of Transfusion Reactions==
==Treatment of Transfusion Reactions==
The most important step in treating a presumed transfusion reaction is to stop the transfusion immediately (saving the remaining blood and IV tubing for testing) and to provide supportive care to the patient. More specific treatments depend on the nature and presumed cause of the transfusion reaction. Most [[hospital]]s and medical centers have transfusion reaction [[Guideline (medical)|protocols]], which specify testing of the blood product and patient for [[hemolysis]], bacterial contamination, etc.
* The most important step in treating a presumed transfusion reaction is to stop the transfusion immediately (saving the remaining blood and IV tubing for testing) and to provide supportive care to the patient.
 
* More specific treatments depend on the nature and presumed cause of the transfusion reaction.  
 
* Most [[hospital]]s and medical centers have transfusion reaction [[Guideline (medical)|protocols]], which specify testing of the blood product and patient for [[hemolysis]], bacterial contamination, etc.
==See also==
The following table shows different types of transfusion reactions along with their treatment:
*[[Blood transfusion]]
{|
 
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion  Reaction
==External links==
! style="background:#4479BA; color: #FFFFFF;" align="center" |Time of onset
*[[ICD-10 Chapter T]]: [http://www3.who.int/icd/currentversion/fr-icd.htm?gt80.htm+t80 World Health Organisation classification] - Complications following infusion, transfusion and therapeutic injection
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Rigors
! style="background:#4479BA; color: #FFFFFF;" align="center" |Rash
! style="background:#4479BA; color: #FFFFFF;" align="center" |Blood Pressure
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional Features
! style="background:#4479BA; color: #FFFFFF;" align="center" |Labs
! style="background:#4479BA; color: #FFFFFF;" align="center" |Treatment
! style="background:#4479BA; color: #FFFFFF;" align="center" |Prevention
! style="background:#4479BA; color: #FFFFFF;" align="center" |Mechanism/
Examples
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Anaphylaxis|Anaphylactic reaction]]
| align="left" style="background:#F5F5F5;" |
* Rapid onset
| align="center" style="background:#F5F5F5;" |−
| align="center" style="background:#F5F5F5;" |−
| align="center" style="background:#F5F5F5;" |−
| align="left" style="background:#F5F5F5;" |
* [[Hypotension]]
| align="left" style="background:#F5F5F5;" |
* [[Wheeze|Wheezing]]
* [[Stridor]]
* [[Cyanosis]]
* Soft tissue [[edema]]
| align="left" style="background:#F5F5F5;" |
* [[Complete blood count|CBC]]
* [[Arterial blood gas|ABG]]
* Type and screen
| align="left" style="background:#F5F5F5;" |
* Stop the transfusion immediately
* S/C epinephrine
* IV epinephrine(in case of severe hypotension)
| align="left" style="background:#F5F5F5;" |
* Avoid clerical errors
* Proper storage record
* Repeat type and screen before transfusion
* Proper blood storage conditions
| align="center" style="background:#F5F5F5;" | [[IgA deficiency]]
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infection|Bacterial Infection]]
| align="left" style="background:#F5F5F5;" |
* Rapid onset
| align="center" style="background:#F5F5F5;" | ++
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |±
| align="left" style="background:#F5F5F5;" |
* Hypotension is common
* Occasionally hypertension
| align="left" style="background:#F5F5F5;" |
* Fever > 2
* Tachycardia
| align="left" style="background:#F5F5F5;" |
* CBC
* Urine complete examination
* Blood and urine culture
* Transfusion set culture
* Clotting profile
| align="left" style="background:#F5F5F5;" |
* Stop the transfusion
* Check identity on blood unit
* Look for clerical errors
* Supportive management(O2 inhalation,normal saline)
* Broad spectrum antibiotics for bacterial infections
* Inform blood bank
| align="left" style="background:#F5F5F5;" |
* Extensive screening of blood
* Decrease storage time
* Leukodepletion
* Bactericidal treatment
| align="center" style="background:#F5F5F5;" |±
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hemolysis|Acute hemolytic reaction]]
| align="left" style="background:#F5F5F5;" |
* Rapid onet
| align="center" style="background:#F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" |±
| align="left" style="background:#F5F5F5;" |
* Hypotension
| align="left" style="background:#F5F5F5;" |
* Chest pain
* Apprehension
* Flank pain
* Dark urine([[Hemoglobinura]])
* [[Renal failure]]
* Oozing from venipuncture site  ( DIC)
| align="left" style="background:#F5F5F5;" |
* CBC
* Urine complete examination
* ABO compatibility
* Serum haptoglobin
* Serum LDL
* Serum bilirubin
* [[Prothrombin time]]
* [[Coomb's test]]=+ve
| align="left" style="background:#F5F5F5;" |
* Stop the transfusion immediately
* Look for clerical errors
* Alert blood bank
* Maintain IV access
* Supportive management
* To prevent renal failure-give low dose dopamine,normal saline,mannitol for diuresis
* Treat DIC(if happens)
| align="left" style="background:#F5F5F5;" |
* Avoid clerical errors
* Proper storage record
* Repeat type and screen before transfusion
* Proper blood storage conditions
| align="center" style="background:#F5F5F5;" |[[ABO incompatibility (patient information)|ABO incompatibility]]
|-
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion  Reaction
! style="background:#4479BA; color: #FFFFFF;" align="center" |Time of onset
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Rigors
! style="background:#4479BA; color: #FFFFFF;" align="center" |Rash
! style="background:#4479BA; color: #FFFFFF;" align="center" |Blood Pressure
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional Features
! style="background:#4479BA; color: #FFFFFF;" align="center" |Labs
! style="background:#4479BA; color: #FFFFFF;" align="center" |Treatment
! style="background:#4479BA; color: #FFFFFF;" align="center" |Prevention
! style="background:#4479BA; color: #FFFFFF;" align="center" |Mechanism/
Examples
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Febrile non-hemolytic transfusion reaction
| align="left" style="background:#F5F5F5;" |
* 1/2 to 1 hour
| align="center" style="background:#F5F5F5;" | +, with chills
| align="center" style="background:#F5F5F5;" |<nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" |−
| align="left" style="background:#F5F5F5;" |
* No Effect
| align="left" style="background:#F5F5F5;" |
* Can occur in first few hours
* Fever rise of 1-2
| align="left" style="background:#F5F5F5;" |
* No labs usually required
| align="left" style="background:#F5F5F5;" |
* Slow or Stop the transfusion
* Give Acetaminophen for fever
| align="left" style="background:#F5F5F5;" |
* Leukoreduction
| align="center" style="background:#F5F5F5;" | Cytokine in storage
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Transfusion related acute lung injury|Transfusion-related acute lung injury]] (TRALI)
| align="center" style="background:#F5F5F5;" |within 6 hours
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |−
| align="left" style="background:#F5F5F5;" |
* Hypotension
| align="left" style="background:#F5F5F5;" |
* Cough
* Pink frothy sputum
* [[Respiratory distress]]
* [[Pulmonary edema]]
| align="left" style="background:#F5F5F5;" |
* ABGs
* CBC
* SpO2 monitoring
* CXR-pulmonary infiltrates
* HLA typing(remove donor from the list)
| align="left" style="background:#F5F5F5;" |
* Stop the transfusion immediately
* O2 inhalation
* Ventilatory support
* Supportive treatment
* Diuretics for volume overload
* Inform the blood bank
* Consult hematologist
| align="left" style="background:#F5F5F5;" |
* Donor whose blood cause TRALI must be put on non-donor list
| align="center" style="background:#F5F5F5;" | Donor anti-leukocyte antibodies
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Transfusion-associated circulatory overload (TACO)
| align="center" style="background:#F5F5F5;" |usually over hours
| align="center" style="background:#F5F5F5;" |−
| align="center" style="background:#F5F5F5;" |−
| align="center" style="background:#F5F5F5;" |−
| align="left" style="background:#F5F5F5;" |
* Hypertension
| align="left" style="background:#F5F5F5;" |
* Dyspnea
* Orthopnea
* Cough
* Headache
* Tachycardia
* Decrease spO2
* Increase JVP
* Increase CVP
| align="left" style="background:#F5F5F5;" |
* SpO2 monitoring
* CXR
* Serum BNP
* ABGs
| align="left" style="background:#F5F5F5;" |
* Stop transfusion
* Supportive therapy
* O2 supplementation
* Ventilatory support
* Diuretics
* Exchange transfusion(if transfusion is unavoidable)
* Controlled phelbotomy
| align="left" style="background:#F5F5F5;" |
* Slow rate of transfusion
* Avoid unnecessary transfusion
* Cardiac evaluation
| align="center" style="background:#F5F5F5;" | +++
|}


== References ==
== References ==
<div class="references-small"><references/></div>
{{reflist|2}}
<div class="references-small">
<references /></div>


{{transfusion medicine}}
[[Category:Transfusion medicine]]
[[Category:Hematology]]
[[Category:Hematology]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 00:42, 31 December 2018

WikiDoc Resources for Transfusion reaction

Articles

Most recent articles on Transfusion reaction

Most cited articles on Transfusion reaction

Review articles on Transfusion reaction

Articles on Transfusion reaction in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Transfusion reaction

Images of Transfusion reaction

Photos of Transfusion reaction

Podcasts & MP3s on Transfusion reaction

Videos on Transfusion reaction

Evidence Based Medicine

Cochrane Collaboration on Transfusion reaction

Bandolier on Transfusion reaction

TRIP on Transfusion reaction

Clinical Trials

Ongoing Trials on Transfusion reaction at Clinical Trials.gov

Trial results on Transfusion reaction

Clinical Trials on Transfusion reaction at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Transfusion reaction

NICE Guidance on Transfusion reaction

NHS PRODIGY Guidance

FDA on Transfusion reaction

CDC on Transfusion reaction

Books

Books on Transfusion reaction

News

Transfusion reaction in the news

Be alerted to news on Transfusion reaction

News trends on Transfusion reaction

Commentary

Blogs on Transfusion reaction

Definitions

Definitions of Transfusion reaction

Patient Resources / Community

Patient resources on Transfusion reaction

Discussion groups on Transfusion reaction

Patient Handouts on Transfusion reaction

Directions to Hospitals Treating Transfusion reaction

Risk calculators and risk factors for Transfusion reaction

Healthcare Provider Resources

Symptoms of Transfusion reaction

Causes & Risk Factors for Transfusion reaction

Diagnostic studies for Transfusion reaction

Treatment of Transfusion reaction

Continuing Medical Education (CME)

CME Programs on Transfusion reaction

International

Transfusion reaction en Espanol

Transfusion reaction en Francais

Business

Transfusion reaction in the Marketplace

Patents on Transfusion reaction

Experimental / Informatics

List of terms related to Transfusion reaction

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Khuram Nouman, M.D. [2] Amandeep Singh M.D.[3]

Overview

Blood products, when transfused even after cross matching, elicit some reactions. The transfusion reactions are classified into anaphylactic reaction, bacterial infection, acute hemolytic reaction, febrile non-hemolytic reaction, transfusion-related acute lung injuryTRALI, transfusion-associated circulatory overload, transfusion-associated microchimerism (TA-MC), iron overload, and transfusion-associated Graft-versus-Host Disease (GvHD). The symptoms may range from fever to life threatening anaphylaxis. The treatment of each different type of transfusion reaction is different.

Types of Transfusion Reactions

Anaphylactic Reaction

Bacterial Infection

  • Blood products can provide an excellent medium for bacterial growth, and can become contaminated after collection while they are being stored.
  • The risk is highest with platelet transfusion, since platelets must be stored near room temperature and cannot be refrigerated.
  • The risk of severe bacterial infection and sepsis is estimated (as of 2001) at about 1 in 50,000 platelet transfusions, and 1 in 500,000 red blood cell transfusions.

Acute Hemolytic Reaction

Febrile Non-hemolytic Transfusion Reaction

  • This is the most common adverse reaction to a blood transfusion.
  • Symptoms include fever and dyspnea 1 to 6 hours after receiving the transfusion.
  • Such reactions are clinically benign, causing no lasting side effects or problems, but are unpleasant via a blood transfusion is estimated, as of 2006, at 1 per 2 million units transfused. Bacterial infection is a much more common problem.

Transfusion-Related Acute Lung Injury (TRALI)

  • TRALI is a syndrome of acute respiratory distress, often associated with fever, non-cardiogenic pulmonary edema, and hypotension.
  • It may occur as often as 1 in 2000 transfusions.
  • Symptoms can range from mild to life-threatening, but most patients recover fully within 96 hours, and the mortality rate from this condition is less than 10%.

Transfusion-associated Microchimerism (TA-MC)

Transfusion-associated Graft-vs-Host Disease (GvHD)

  • GVHD refers to an immune attack by transfused cells against the recipient. This is a common complication of stem cell transplantation, but an exceedingly rare complication of blood transfusion.
  • It occurs only in severely immunosuppressed patients, primarily those with congenital immune deficiencies or hematologic malignancies who are receiving intensive chemotherapy.
  • When GVHD occurs in association with blood transfusion, it is almost uniformly fatal. Transfusion-associated GVHD can be prevented by irradiating the blood products prior to transfusion.

Volume Overload

  • Patients with impaired cardiac function (e.g. congestive heart failure) can become volume-overloaded as a result of blood transfusion, leading to edema, dyspnea (shortness of breath), and orthopnea (shortness of breath while lying flat).
  • This is sometimes called TACO, or Transfusion Associated Circulatory Overload.[1]

Iron Overload

  • Each transfused unit of red blood cells contains approximately 250 mg of elemental iron.
  • Since elimination pathways for iron are limited, a person receiving numerous red blood cell transfusions can develop iron overload, which can in turn damage the liver, heart, kidneys, and pancreas. The threshold at which iron overload becomes significant is somewhat unclear, but is likely around 12-20 units of red blood cells transfused.

Following table summarizes the difference between transfusion-related acute lung injury (TRALI) and transfusion associated circulatory overload (TACO):

Parameters Transfusion-related acute lung injury (TRALI) Transfusion-associated circulatory overload (TACO)
Fever ±
Blood pressure Hypotension Hypertension
Respiratory distress + +
JVP Non-distended Distended
Respiratory auscultation Rales Rales + S3 heart sounds may be present
CXR Bilateral pulmonary infiltrates Bilateral pulmonary infiltrates
Fluid balance Neutral Positive
Diuretics Responsive only when there is fluid overload Improvement with diuretics
Ejection fraction Normal Decreased
BNP <250 pg/mL >1200 pg/mL
PCWP <18 mm Hg >18 mm Hg
WBC Unchanged Transient decreased

Treatment of Transfusion Reactions

  • The most important step in treating a presumed transfusion reaction is to stop the transfusion immediately (saving the remaining blood and IV tubing for testing) and to provide supportive care to the patient.
  • More specific treatments depend on the nature and presumed cause of the transfusion reaction.
  • Most hospitals and medical centers have transfusion reaction protocols, which specify testing of the blood product and patient for hemolysis, bacterial contamination, etc.

The following table shows different types of transfusion reactions along with their treatment:

Transfusion Reaction Time of onset Fever Rigors Rash Blood Pressure Additional Features Labs Treatment Prevention Mechanism/

Examples

Anaphylactic reaction
  • Rapid onset
  • Stop the transfusion immediately
  • S/C epinephrine
  • IV epinephrine(in case of severe hypotension)
  • Avoid clerical errors
  • Proper storage record
  • Repeat type and screen before transfusion
  • Proper blood storage conditions
IgA deficiency
Bacterial Infection
  • Rapid onset
++ + ±
  • Hypotension is common
  • Occasionally hypertension
  • Fever > 2
  • Tachycardia
  • CBC
  • Urine complete examination
  • Blood and urine culture
  • Transfusion set culture
  • Clotting profile
  • Stop the transfusion
  • Check identity on blood unit
  • Look for clerical errors
  • Supportive management(O2 inhalation,normal saline)
  • Broad spectrum antibiotics for bacterial infections
  • Inform blood bank
  • Extensive screening of blood
  • Decrease storage time
  • Leukodepletion
  • Bactericidal treatment
±
Acute hemolytic reaction
  • Rapid onet
+ + ±
  • Hypotension
  • Stop the transfusion immediately
  • Look for clerical errors
  • Alert blood bank
  • Maintain IV access
  • Supportive management
  • To prevent renal failure-give low dose dopamine,normal saline,mannitol for diuresis
  • Treat DIC(if happens)
  • Avoid clerical errors
  • Proper storage record
  • Repeat type and screen before transfusion
  • Proper blood storage conditions
ABO incompatibility
Transfusion Reaction Time of onset Fever Rigors Rash Blood Pressure Additional Features Labs Treatment Prevention Mechanism/

Examples

Febrile non-hemolytic transfusion reaction
  • 1/2 to 1 hour
+, with chills +
  • No Effect
  • Can occur in first few hours
  • Fever rise of 1-2
  • No labs usually required
  • Slow or Stop the transfusion
  • Give Acetaminophen for fever
  • Leukoreduction
Cytokine in storage
Transfusion-related acute lung injury (TRALI) within 6 hours ± ±
  • Hypotension
  • ABGs
  • CBC
  • SpO2 monitoring
  • CXR-pulmonary infiltrates
  • HLA typing(remove donor from the list)
  • Stop the transfusion immediately
  • O2 inhalation
  • Ventilatory support
  • Supportive treatment
  • Diuretics for volume overload
  • Inform the blood bank
  • Consult hematologist
  • Donor whose blood cause TRALI must be put on non-donor list
Donor anti-leukocyte antibodies
Transfusion-associated circulatory overload (TACO) usually over hours
  • Hypertension
  • Dyspnea
  • Orthopnea
  • Cough
  • Headache
  • Tachycardia
  • Decrease spO2
  • Increase JVP
  • Increase CVP
  • SpO2 monitoring
  • CXR
  • Serum BNP
  • ABGs
  • Stop transfusion
  • Supportive therapy
  • O2 supplementation
  • Ventilatory support
  • Diuretics
  • Exchange transfusion(if transfusion is unavoidable)
  • Controlled phelbotomy
  • Slow rate of transfusion
  • Avoid unnecessary transfusion
  • Cardiac evaluation
+++

References

  1. Suddock JT, Crookston KP. Transfusion Reactions. [Updated 2018 Sep 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482202/